346
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients

, , , , &
Pages 2630-2636 | Received 28 Mar 2014, Accepted 29 Dec 2014, Published online: 04 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yajun Li, Kailin Chen, Chaohui Zuo, Ruolan Zeng, Yizi He, Xiaoyan Chen, Ling Xiao & Hui Zhou. (2021) Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER. International Journal of General Medicine 14, pages 8399-8411.
Read now

Articles from other publishers (10)

Zhi-Nan Fan, Hong-Jin Shi, Bo-Bo Xiong, Jin-Song Zhang, Hai-Feng Wang & Jian-Song Wang. (2022) Primary adrenal diffuse large B-cell lymphoma with normal adrenal cortex function: A case report. World Journal of Clinical Cases 10:2, pages 709-716.
Crossref
Fabian Huber, Elisabeth Zwickl-Traxler, Martin Pecherstorfer & Josef Singer. (2021) Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma—A Single-Center Retrospective Cohort Study. Current Oncology 28:6, pages 4521-4529.
Crossref
Antonin Bouroumeau, Lucile Bussot, Thierry Bonnefoix, Cyril Fournier, Caroline Chapusot, Olivier Casasnovas, Laurent Martin, Anne McLeer, Edwige Col, Laurence David‐Boudet, Christine Lefebvre, Caroline Algrin, Tatiana Raskovalova, Marie‐Christine Jacob, Claire Vettier, Simon Chevalier, Mary B Callanan, Rémy Gressin, Anouk Emadali & Hervé Sartelet. (2021) c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP ‐treated diffuse large B‐cell lymphoma . The Journal of Pathology: Clinical Research 7:6, pages 604-615.
Crossref
Daisuke Usuda, Toshihide Izumida, Nao Terada, Ryusho Sangen, Toshihiro Higashikawa, Sayumi Sekiguchi, Risa Tanaka, Makoto Suzuki, Yuta Hotchi, Shintaro Shimozawa, Shungo Tokunaga, Ippei Osugi, Risa Katou, Sakurako Ito, Suguru Asako, Yoshie Takagi, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Jiro Oba, Tomohisa Nomura, Manabu Sugita & Yuji Kasamaki. (2021) Diffuse large B cell lymphoma originating from the maxillary sinus with skin metastases: A case report and review of literature. World Journal of Clinical Cases 9:23, pages 6886-6899.
Crossref
Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla & Vassiliki Pappa. (2021) Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications. Therapeutic Advances in Hematology 12, pages 204062072110139.
Crossref
Hans-Jonas Meyer, Andreas Wienke & Alexey Surov. (2019) Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 19:6, pages e266-e272.
Crossref
H. Dorota Halicka. (2018) Where to “cut-off”?. Cytometry Part A 93:11, pages 1092-1093.
Crossref
Sheng-Tsung Chang, Shang-Wen Chen, Chung-Han Ho, Chun-Chi Kuo, Seiji Sakata, Kengo Takeuchi & Shih-Sung Chuang. (2016) Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan. Journal of the Formosan Medical Association 115:11, pages 961-967.
Crossref
Penelope Korkolopoulou, Theodoros Vassilakopoulos, Vassilios Milionis & Maria Ioannou. (2016) Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review. Advances in Anatomic Pathology 23:4, pages 202-243.
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology 6-66 6-75 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.